| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 39,70% | 13,94% | -31,06% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 43,98% | 15,25% | -24,62% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 40,03% | 14,67% | -30,61% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 44,36% | 16,04% | -24,12% | · |
| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 43,68% | 15,04% | -24,82% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 38,05% | 9,90% | -35,30% | · |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 42,28% | 11,06% | -29,46% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 40,25% | 15,13% | -30,18% | · |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 44,59% | 16,50% | -23,66% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 44,42% | 16,09% | -23,74% | · |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 40,11% | 14,82% | -30,47% | · |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 17,43% | 19,31% | 4,76% | · |
| JPM TOTAL EMERGING MARKETS INCOME I2 (ACC) EUR (HEDGED) | MIXTO AGRESIVO GLOBAL | 19,47% | 39,43% | 23,05% | · |
| JPM TOTAL EMERGING MARKETS INCOME I (DIST) EUR (HEDGED) | MIXTO AGRESIVO GLOBAL | 14,42% | 21,94% | 0,66% | · |
| JPM US AGGREGATE BOND C (DIST) EUR (HEDGED) | RFI USA | -3,90% | -5,16% | -20,37% | · |
| JPM US AGGREGATE BOND I2 (ACC) EUR (HEDGED) | RFI USA | 1,04% | 5,97% | -9,42% | · |
| JPM US AGGREGATE BOND I2 (ACC) USD | RFI USA | 5,70% | 9,44% | 3,22% | · |
| JPM US AGGREGATE BOND I2 (DIST) CHF (HEDGED) | RFI USA | -3,10% | -6,61% | -13,87% | · |
| JPM US AGGREGATE BOND I2 (DIST) EUR (HEDGED) | RFI USA | -2,38% | -4,09% | -22,26% | · |
| JPM US AGGREGATE BOND I2 (DIST) GBP (HEDGED) | RFI USA | 0,93% | 1,52% | -18,34% | · |
